Browse by all authors Browse By Author Name - Gill,+Devinder

Browse Results (35 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Lane, Steven, Saal, Russell, Mollee, Peter, Jones, Mark, Grigg, Andrew, Taylor, Kerry, Seymour, John, Kennedy, Glen, Williams, Bronwyn, Grimmett, Karen, Griffiths, Vanessa, Gill, Devinder, Hourigan, Matthew and Marlton, Paula (2008) A 1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor accute myeloid leukemia and predicts subsequent morphologic relapse. Leukemia & Lymphoma, 49 3: 517-523. doi:10.1080/10428190701817266 151   21 Cited 18 times in Scopus18 0
Tate, Jillian R., Mollee, Peter, Dimeski, Goce, Carter, Andrew C. and Gill, Devinder (2007) Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Clinica Chimica Acta, 376 1-2: 30-36. doi:10.1016/j.cca.2006.07.011 69   48 Cited 60 times in Scopus60 0
Tate, Jillian R., Mollee, Peter, Dimeski, Goce, Carter, Andrew C. and Gill, Devinder (2007) Analytical performance of serum free light-chains assay. Clinica Chimica Acta, 380 1-2: 250-251. doi:10.1016/j.cca.2007.02.004 23   0 Cited 4 times in Scopus4 0
Hourigan, Matthew J., Doecke, James, Mollee, Peter N., Gill, Devinder S., Norris, Debra, Johnson, David W. and Gandhi, Maher K. (2008) A new prognosticator for post-transplant lymphoproliferative disorders after renal transplantation. British Journal of Haematology, 141 6: 904-907. doi:10.1111/j.1365-2141.2008.07149.x 87   13 Cited 13 times in Scopus13 0
Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy and Gill, Devinder S. (2011). A Phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. In: ASH Annual Meeting Abstracts 2011. 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH), San Diego, CA, United States, (1700-1700). Dec 10-13, 2011. 39   0
Mollee, Peter, Tiley, Campbell, Cunningham, Ilona, Moore, John, Prince, H.Miles, Cannell, Paul, Gibbons, Steve, Tate, Jill, Paul, Sanjoy, Fan, Helen Mar and Gill, Devinder S. (2012) A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis. British Journal of Haematology, 157 6: 766-769. doi:10.1111/j.1365-2141.2012.09080.x 57   5 Cited 4 times in Scopus4 1
Herzig, Karen A., Juffs, Helen G., Norris, Debra, Brown, Allison M., Gill, Devinder, Hawley, Carmel M., Cobcroft, Ralph, Petrie, James B., Marlton, Paula, Thomson, Damien, Campbell, Scott B., Nicol, David L. and Johnson, David W. (2003) A single-centre experience of post-renal transplant lymphoproliferative disorder. Transplant International, 16 7: 529-536. doi:10.1007/s00147-003-0596-0 121   23 Cited 27 times in Scopus27 0
Juffs, Helen, Fowler, Nina, Saal, Russell, Grimmett, Karen, Beasley, Shannon, O'Sullivan, Brendan, Frazer, Ian H., Gill, Devinder and Thomas, Ranjeny (2004) B cell chronic lymphocytic leukaemia cells have reduced capacity to upregulate expression of MHC class I in response to interferon-gamma. Pathology, 36 1: 69-76. doi:10.1080/00313020310001644499 138   5 Cited 5 times in Scopus5 0
Burgess, Melinda, Cheung, Catherine, Chambers, Lynne, Ravindranath, Karunya, Minhas, Gunjeet, Knop, Louise, Mollee, Peter, McMillan, Nigel A. J. and Gill, Devinder (2012) CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro. Leukemia and Lymphoma, 53 10: 1988-1998. doi:10.3109/10428194.2012.672735 78   13 Cited 8 times in Scopus8 0
Keane, Colm, Gill, Devinder, Vari, Frank, Cross, Donna, Griffiths, Lynn and Gandhi, Maher (2013) CD4+Tumor infiltrating lymphocytes are prognostic and independent of R-IPI in patients with DLBCL receiving R-CHOP chemo-immunotherapy. American Journal of Hematology, 88 4: 273-276. doi:10.1002/ajh.23398 48   3 Cited 3 times in Scopus3 1
Burgess, Melinda, Gill, Devinder, Singhania, Richa, Cheung, Catherine, Chambers, Lynne, Renyolds, Brent A., Smith, Louise, Mollee, Peter, Saunders, Nicholas and McMillan, Nigel A. J. (2013) CD62L as a therapeutic target in chronic lymphocytic leukemia. Clinical Cancer Research, 19 20: 5675-5685. doi:10.1158/1078-0432.CCR-13-1037 48   1 Cited 2 times in Scopus2 3
Spencer, Andrew, Prince, H. Miles, Roberts, Andrew W., Prosser, Ian W., Bradstock, Kenneth F., Coyle, Luke, Gill, Devinder S., Horvath, Noemi, Reynolds, John and Kennedy, Nola (2009) Consolidation therapy with low-dose thalidomide and prednisolone prolongs the survival of multiple myeloma patients undergoing a single autologous stem-cell transplantation procedure. Journal of Clinical Oncology, 27 11: 1788-1793. doi:10.1200/JCO.2008.18.8573 141   170 Cited 198 times in Scopus198 0
Nehring, Angela K., Dua, Ujjwal, Mollee, Peter, Gill, Devinder, Grimmett, Karen, Khanna, Rajiv, Moss, Denis and Gandhi, Maher K. (2007) Epstein-Barr virus T-cell immunity despite rituximab. British Journal of Haematology, 136 4: 628-632. doi:10.1111/j.1365-2141.2006.06482.x 90   8 Cited 9 times in Scopus9 0
Mollee, Peter, Tate, Jill, Dimeski, Goce and Gill, Devinder (2005). Falsely low serum free light chain concentration in patients with monoclonal light chain diseases. In: ASH Annual Meeting Abstracts, 2005. 47th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA, United States, (351-351). 10-13 December 2005. 29   0
Gandhi, Maher K., Moll, Guido, Smith, Corey, Dua, Ujjwal, Lambley, Eleanore, Ramuz, Olivier, Gill, Devinder, Marlton, Paula, Seymour, John F. and Khanna, Rajiv (2007) Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma. Blood, 110 4: 1326-1329. doi:10.1182/blood-2007-01-066100 127   62 Cited 73 times in Scopus73 3
Mutsando, Howard, Fahim, Magid, Gill, Devinder S., Hawley, Carmel M., Johnson, David W., Maher, K. Gandhi, Marlton, Paula V., Mar Fan, Helen G. and Mollee, Peter N. (2012) High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease. American Journal of Blood Research, 2 1: 66-70. 49 3
Gill, Devinder, Burgess, Melinda, Knop, Louise, Mollee, Peter and McMillan, Nigel (2008). Identification of two novel chemokines (CCL2 and CXCL2) in B-chronic lymphocytic leukaemia (B-CLL) and prolonged survival of primary B-CLL cells in vitro. In: ASH Annual Meeting Abstracts, 20098. 50th Annual Meeting of the American- Society-of-Hematology, San Francisco, CA, United States, (1082-1083). 6 - 9 December 2008. 45   0
Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. In: American Journal of Transplantation. American Transplant Congress, San Francisco, CA, USA, (399-399). 5-9 May 2007. doi:10.1111/j.1600-6143.2007.01811.x 84   0 0
Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. In: P. Halloran, American Journal of Transplantation: Proceedings of the American Transplant Congress 2007. American Transplant Congress 2007, USA, (399-399). 5-9 May 2007. doi:10.1111/j.1600-6143.2007.01811.x 165   0 0
Tran, Huy, Cheung, Catherine, Gill, Devinder, Dua, Ujjwal, Nourse, Jamie, Boyle, Richard and Gandhi, Maher K. (2008) Methotrexate-associated mantle-cell lymphoma in an elderly man with myasthenia gravis. Nature Clinical Practice Oncology, 5 4: 234-238. doi:10.1038/ncponc1071 45   2 Cited 6 times in Scopus6 0
Kennedy, Glen A., Kay, Troy D., Johnson, D. W., Hawley, Carmel M., Campbell, Scott B., Isbel, Nikky M.., Marlton, Paula, Cobcroft, Ralph, Gill, Devinder and Cull, Gavin (2002) Neutrophil dysplasia characterised by a pseudo-Pelger-Huet anomaly occurring with the use of mycophenolate mofetil and ganciclovir following renal transplantation: a report of five cases. Pathology, 34 3: 263-266. doi:10.1080/0031302022013136 165   16 Cited 21 times in Scopus21 0
Morris, Kirk, Weston, Helen, Mollee, Peter, Marlton, Paula, Gill, Devinder and Kennedy, Glen (2011) Outcome of treatment of adult acute lymphoblastic leukemia with hyperfractionated cyclophosphamide, doxorubicin, vincristine, dexamethasone/methotrexate, cytarabine: Results from an Australian population. Leukemia and Lymphoma, 52 1: 85-91. doi:10.3109/10428194.2010.532889 56 3 9 Cited 10 times in Scopus10 0
Panwar, Rakshit, Venkatesh, Bala, Kruger, Peter, Bird, Robert, Gill, Devinder, Nunnink, Leo and Dimeski, Goce (2009) Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study. Journal of Hematology and Oncology, 2 43: xx-xx. doi:10.1186/1756-8722-2-43 79   1 Cited 1 times in Scopus1 0
Tey, Siok-Keen, Marlton, Paula V., Hawley, Carmel M., Norris, Debra and Gill, Devinder S. (2008) Post-transplant hepatosplenic T-cell lymphoma successfully treated with hyperCVAD regimen. American Journal of Hematology, 83 4: 330-333. doi:10.1002/ajh.21062 62   13 Cited 15 times in Scopus15 0
Adams, Rebecca L. C., Cheung, Catherine, Banh, Raymond, Saal, Russell, Cross, Donna, Gill, Devinder, Self, Marlene, Klein, Kerenaftali and Mollee, Peter (2014) Prognostic value of ZAP-70 expression in chronic lymphocytic leukemia as assessed by quantitative polymerase chain reaction and flow cytometry. Cytometry Part B - Clinical Cytometry, 86 2: 80-90. doi:10.1002/cyto.b.21138 30   4 Cited 2 times in Scopus2 0
Lane, Steven W., Gill, Devinder, Mollee, Peter N. and Rajkumar, S. Vincent (2005) Role of VAD in the initial treatment of multiple myeloma. Blood, 106 10: 3674-3675. doi:10.1182/blood-2005-07-2610 52   9 Cited 8 times in Scopus8 0
Lane, Steven W., Crawford, Julie, Kenealy, Melita, Cull, Gavin, Seymour, John F., Prince, H. Miles, Marlton, Paula, Gill, Devinder ‌ and Mollee, Peter‌ N. (2006) Safety and efficacy of pegfilgrastim compared to granulocyte colony stimulating factor (G-CSF)supporting a dose-intensive, rapidly cycling anti-metabolite containing chemotherapy regimen (Hyper-CVAD) for lymphoid malignancy. Leukemia and Lymphoma, 47 9: 1813-1817. doi:10.1080/10428190600632832 162   10 Cited 11 times in Scopus11 0
Jones, Kimberley, Vari, Frank, Keane, Colm, Crooks, Pauline, Nourse, Jamie P., Seymour, Louise A., Gottlieb, David, Ritchie, David, Gill, Devinder and Gandhi, Maher K. (2013) Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Clinical Cancer Research, 19 3: 731-742. doi:10.1158/1078-0432.CCR-12-2693 54   13 Cited 14 times in Scopus14 7
Keane, Colm, Gibbs, Simon, Seymour, John F., Mills, Anthony K ., Grimmett, Karen, Van Kuilenberg, Rosita, Russell, Saal, Gill, Devinder, Prince, H. Miles, Marlton, Paula and Mollee, Peter (2006) The Hyper-CVAD chemotherapy regimen has an adverse long-term impact on the ability to mobilize peripheral blood stem cells, which can be readily circumvented by using the early cycles for mobilization. Hematological Oncology, 24 3: 159-163. doi:10.1002/hon.784 164   10 Cited 12 times in Scopus12 0
Tate, Jillian R., Mollee, Peter and Gill, Devinder (2005) The reporting of serum protein electrophoresis to clinicians. Clinica Chimica Acta, 358 1-2: 204-205. doi:10.1016/j.cccn.2005.04.010 40   2 Cited 3 times in Scopus3 0
Keane, Colm, Mollee, Peter, Marlton, Paula and Gill, Devinder (2011) Treatment of acute promyelocytic leukaemia in the Jehovah's Witness population. Annals of Hematology, 90 3: 359-360. doi:10.1007/s00277-010-1023-0 27   0 Cited 1 times in Scopus1 0
Jones, Kimberley, Nourse, Jamie P., Keane, Colm, Crooks, Pauline, Gottlieb, David, Ritchie, David S., Gill, Devinder and Gandhi, Maher K. (2012) Tumor-specific but not nonspecific cell-free circulating DNA can be used to monitor disease response in lymphoma. American Journal of Hematology, 87 3: 258-265. doi:10.1002/ajh.22252 175   4 Cited 4 times in Scopus4 1
Lane, Steven, Gill, Devinder, McMillan, Nigel A. J., Saunders, Nicholas, Murphy, Rachel, Spurr, Terrence, Keane, Colm, Fan, Helen Mar and Mollee, Peter (2012) Valproic acid combined with cytosine arabinoside in elderly patients with acute myeloid leukemia has in vitro but limited clinical activity. Leukemia & Lymphoma, 53 6: 1077-1083. doi:10.3109/10428194.2011.642302 81   4 Cited 5 times in Scopus5 1
Maung, Kyaw Zeya, Gray, James X., Leo, Paul J., Bassal, Mahmoud, Brown, Anna L., Bray, Sarah C., Tiong, Ing Soo, Kok, Chung H., Deans, Andrew, Marshall, Mhairi, Gardiner, Brooke, Glazov, Evgeny A., Marlton, Paula, Gill, Devinder, Bik, Luen, Lewis, Ian D., D'Andrea, Richard J. and Gonda, Thomas J. (2014). Whole Exome Sequencing of Acute Myeloid Leukaemia Patients Identifies Somatic and Germline Mutations in Fanconi Anaemia Genes. In: Blood. 56th Annual Meeting of the American-Society-of-Hematology, San Francisco Ca, (). Dec 06-09, 2014. 51   0
Gray, James X., McMillen, Lyle, Mollee, Peter, Paul, Sanjoy, Lane, Steven, Bird, Robert, Gill, Devinder, Saal, Russell and Marlton, Paula (2012) WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation. Leukemia Research, 36 4: 453-458. doi:10.1016/j.leukres.2011.09.005 49   9 Cited 11 times in Scopus11 0